RecruitingNot applicableNCT04909138

Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy

Studying OBSOLETE: Acquired metabolic neuropathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rush University Medical Center
Principal Investigator
Robert McCarthy, PharmD
Rush University Medical Center
Intervention
DRG stimulation 20 Hz 30/90(device)
Enrollment
30 enrolled
Eligibility
18-90 years · All sexes
Timeline
20222027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04909138 on ClinicalTrials.gov

Other trials for OBSOLETE: Acquired metabolic neuropathy

Additional recruiting or active studies for the same condition.

See all trials for OBSOLETE: Acquired metabolic neuropathy

← Back to all trials